Figure 6
From: Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis
Receiver-Operator Curve (ROC) Analysis for High Serum Fibrinogen Proteins in MG. The results of the targeted proteomic analysis of Fibrinogen-α/β/γ of the patient cohort (Table 1) shown in Fig. 4 were analyzed for each Fibrinogen form indicated using ROCs comparing MG patients (n = 31) and the combined population (n = 48) of controls and RA patients. The areas under the curve and their 95% confidence intervals in addition to the specificities (True Positive Rate) and sensitivities (True Negative Rate) for each protein are provided in their respective inserts.
